The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase
- 1 October 2003
- journal article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 21 (10), 1879-1885
- https://doi.org/10.1097/00004872-200310000-00015
Abstract
The present study intended to investigate whether the impaired H2S synthase/H2S pathway is associated with hypertension. Hypertension in Wistar rats was induced by the oral administration of the l-arginine analog, NG-nitro-l-arginine methyl ester (l-NAME) in their drinking water for a period of 6 weeks. The control rats were given plain tap water only. Sodium hydrosulfide (NaHS) was given by intraperitoneal injection to both the control group and the l-NAME-treated group. The systolic BP (blood pressure) was measured by a tail-cuff method using a pulse transducer. Plasma hydrogen sulfide (H2S), and H2S generation by thoracic aorta and superior mesenteric artery, were determined. In addition, the activity of cystathionine-gamma-lyase (CSE) in thoracic aorta and superior mesenteric artery, most responsible for H2S production, was also measured. Competitive reverse transcriptase-polymerase chain reaction (RT-PCR) was used to determine CSE mRNA in thoracic aorta. l-NAME caused a time-dependent elevation of systolic BP. The heart-to-body weight ratio of l-NAME-treated rats was 27% higher than that of controls. The systolic BP in the NaHS-treated l-NAME group was significantly decreased, by 19% (P < 0.01), in comparison with the l-NAME group. The heart-to-body weight ratio decreased significantly by 12%. l-NAME inhibited CSE gene expression significantly. The inhibition of H2S generation and CSE activity by l-NAME was greatly attenuated in the NaHS-treated l-NAME group. However, there was no significant difference in nitric oxide (NO) generation between the l-NAME group and the NaHS-treated l-NAME group. In summary, dysfunction of the vascular H2S synthase/H2S pathway was found in l-NAME-induced hypertensive rats. Exogenous H2S effectively prevented the development of hypertension induced by l-NAME. These findings suggest that the H2S synthase/H2S pathway participates in hypertension.Keywords
This publication has 14 references indexed in Scilit:
- Increased sensitivity of the obese Zucker rat to deoxycorticosterone-salt-induced hypertensionJournal Of Hypertension, 2002
- NG-Nitro-l-Arginine Methyl Ester–Induced Hypertension and Natriuretic Peptide Gene Expression: Inhibition by Angiotensin II Type 1 Receptor AntagonismJournal of Cardiovascular Pharmacology, 2002
- The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel openerThe EMBO Journal, 2001
- Effect of propargylglycine on synthesis of glutathione in miceNutrition Research, 2001
- KCNQ4 channels expressed in mammalian cells: functional characteristics and pharmacologyAmerican Journal of Physiology-Cell Physiology, 2001
- Nitric oxide: comparative synthesis and signaling in animal and plant cellsTrends in Plant Science, 2001
- Angiotensin-Converting Enzyme Inhibitors and AT1-Receptor Antagonist Restore Nitric Oxide Synthase (NOS) Activity and Neuronal NOS Expression in the Adrenal Glands of Spontaneously Hypertensive RatsThe Japanese Journal of Pharmacology, 2001
- The Possible Role of Hydrogen Sulfide as an Endogenous Smooth Muscle Relaxant in Synergy with Nitric OxideBiochemical and Biophysical Research Communications, 1997
- Blood Pressure and Vascular Effects of Endothelin Blockade in Chronic Nitric Oxide–Deficient HypertensionHypertension, 1997
- Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the ratBiochemical Journal, 1982